Today: 9 April 2026
Salesforce stock tries to stabilize after AI “software-mageddon” — Feb. 25 earnings is the next test

Salesforce stock tries to stabilize after AI “software-mageddon” — Feb. 25 earnings is the next test

New York, Feb 6, 2026, 11:23 (EST) — Regular session

Salesforce shares edged up 0.1% to $190.07 in late-morning trading on Friday, following a session range from $187.29 to $194.52.

The modest dip caps a tough week for Salesforce, as investors unravel the broad “AI trade” and begin to treat software as a possible loser instead of a winner. Salesforce has dropped 9% this week, according to Reuters data. Saxo’s Charu Chanana noted that investors are now “differentiating between who enables AI and who may be disrupted.” Reuters

Salesforce is set to release its fourth-quarter and full-year results on Feb. 25, after markets close. The company will hold a conference call at 5 p.m. Eastern that day. Salesforce Investor Relations

Much of the pressure comes from how fast new AI tools are embedding themselves into software people already rely on. On Thursday, Anthropic rolled out Claude Opus 4.6, an upgraded model boasting longer task handling and improvements in coding and finance. They also teased the ability to process up to 1 million “tokens” — units of text for running prompts — and split tasks across multiple independent agents in their Claude Code feature. Scott White from Anthropic called Claude Cowork “the front door to getting hard work done.” Reuters

The sector slide has turned chaotic, pushing the S&P 500 software and services index down 4.6% on Thursday. This extended the so-called “software-mageddon” selloff, wiping out roughly $1 trillion in market value since Jan. 28. Salesforce shares dropped 4.7% in the session. “I would classify this as a sell-everything mindset at this point,” said Dave Harrison Smith, chief investment officer at Bailard. Goldman Sachs strategist Ben Snider added that “near-term earnings results will be important signals of business resilience.” Reuters

The day before, investors debated whether the sell-off had gone too far after a Claude plug-in designed for legal work showed just how quickly AI is encroaching on the “application layer” — the everyday software people rely on. James St. Aubin of Ocean Park Asset Management called it “an awakening to the disruptive power of AI.” On the other hand, JPMorgan’s Mark Murphy described it as “an illogical leap” to think that a new plug-in could replace layers of mission-critical enterprise software. Reuters

Traders’ main concern centers on the revenue model. Enterprise software largely operates on a software-as-a-service (SaaS) basis, with subscriptions charged per user. If AI agents cut down the number of seats a company requires, that growth could stall.

Salesforce now faces added pressure to gauge customer demand accurately. Investors care less about the details of a single quarter and more about whether businesses will continue investing in comprehensive toolkits or pivot toward cutting-edge AI platforms.

The downside isn’t set in stone. If adoption drags or companies hold onto current systems for security, compliance, and workflow reasons, the group could bounce back fast once forced selling eases.

For now, every fresh AI rollout sparks headline risk, and markets swiftly slam shares at the hint of automation threats.

Salesforce’s earnings report and outlook set for Feb. 25 will be the next major catalyst. Investors will zero in on renewal rates and whether there’s any change in customer spending forecasts for 2026.

Stock Market Today

  • QuidelOrtho (QDEL) Shares Slide 23% in a Month Amid Valuation Debate
    April 8, 2026, 9:37 PM EDT. QuidelOrtho (QDEL) shares slipped 22.86% over the past month to $15.32, despite a 2.27% gain on the latest trading day. The stock's 1-year total shareholder return tallies 46.90%, showing past momentum is fading. Analysts flag a sharp valuation gap: market price trails the $34.67 fair value estimate by over 80%, spotlighting risks in execution and reimbursement trends. Expansion into global markets like Latin America and Asia Pacific offers growth potential, underpinned by demand for early detection and immunoassay technologies. But COVID testing normalization and product discontinuations weigh on revenue diversity and margins. Investors should weigh these mixed signals carefully and consider broadening healthcare AI exposure rather than concentrating on one stock story.

Latest article

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Alphabet Stock (GOOG, GOOGL) Faces Split Fund Bets Ahead of Earnings After Fresh 13F Reports

Alphabet Stock (GOOG, GOOGL) Faces Split Fund Bets Ahead of Earnings After Fresh 13F Reports

8 April 2026
Zevenbergen Capital increased its Alphabet Class A share holdings by 27.4% in Q4, while Lombard Odier and Empirical Wealth Management reduced their Class C positions, according to April 7 filings. Alphabet will report first-quarter results on April 29. GOOG and GOOGL traded near $304 before Wednesday’s U.S. open. The filings reflect holdings as of December 31 and may not show current positions.
Sirius XM stock drops after earnings pop fades as traders weigh 2026 cash-flow target
Previous Story

Sirius XM stock drops after earnings pop fades as traders weigh 2026 cash-flow target

Qualcomm stock price ticks up as QCOM steadies after memory-shortage warning spooks chip investors
Next Story

Qualcomm stock price ticks up as QCOM steadies after memory-shortage warning spooks chip investors

Go toTop